Skip to main content

Table 2 Correlation between clinico-pathological features and the expressions of EMMPRIN in NSCLC tissues (n=55)

From: Overexpression of EMMPRIN is associated with lymph node metastasis and advanced stage of non-small cell lung cancer: a retrospective study

Items

Groups

N

Expressions of EMMPRIN in lung tissues

Negative (%)

Positive (%)

χ2 value

P value

Resourse

 

Normal

55

41(74.5)

14(25.5)

8.591

0.003

 

NSCLC

55

26(47.3)

29(52.7)

Gender

 

Male

36

19(52.8)

17(47.2)

1.267

0.260

 

Female

19

7(36.8)

12(63.2)

Ages

 

<60

27

13(48.1)

14(51.9)

0.016

0.898

 

≥60

28

13(46.4)

15(53.6)

Smoking

 

Yes

21

13(61.9)

8(38.1)

2.918

0.088

 

No

34

13(38.2)

21(61.8)

Histology

 

LAC

23

7(30.4)

16(69.6)

4.496

0.034

 

LSCC

32

19(59.4)

13(40.6)

Pathological grade

 

Poorly

17

2(11.8)

15(88.2)

20.762

<0.001

 

Moderately

13

4(30.8)

9(69.2)

 

Well

25

20(80)

5(20)

Lymphatic invasion

 

N0 - N1

26

20(76.9)

6(23.1)

17.392

<0.001

 

N2 - N3

29

6(20.7)

23(79.3)

pTNM

 

IIA-IIIA

35

24(68.6)

11(31.4)

17.517

<0.001

 

IIIB

20

2(10)

18(90)

  1. LAC, lung adenocarcinoma; LSCC, lung squamous cell carcinoma; Smoking, pack years of smoking; T stage, tumor size; pTNM, clinical stage of lung cancer